AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimpure MV 3.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimpure MV 3.3 Tablet SR

Diabeticare SR 3.3 tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. They help manage blood glucose. Diabeticare SR 3.3 should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Carry readily-available glucose sources, such as sweets or juice, and maintain regular meals. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with blood cell count and liver function tests, may be recommended by your doctor.

Uses of Glimpure MV 3.3 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimpure MV 3.3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimpure MV 3.3 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimpure MV 3.3 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimpure MV 3.3 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimpure MV 3.3 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Glimpure MV 3.3 Tablet SR works:

Glimpure MV 3.3 Extended-Release Tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure MV 3.3 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpure MV 3.3 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimpure MV 3.3 Tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, possibly endangering the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimpure MV 3.3 Tablet SR is potentially hazardous for individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimpure MV 3.3 Tablet SR cautiously, potentially requiring dose modification. Consultation with a physician is advisable. For those with mild to moderate liver disease, initiation should involve a low Glimpure MV 3.3 Tablet SR dosage; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimpure MV 3.3 Tablet SR :

Should you forget a dose of Glimpure MV 3.3 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpure MV 3.3 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimpure MV 3.3 Tablet SR

Glimpure MV 3.3 SR tablets contain a triple medication formulation: glimepiride, metformin, and voglibose. This medication is prescribed for managing type 2 diabetes mellitus in adults. Effective blood sugar control is achieved when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by reducing hepatic glucose production and enhancing insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar levels. This combination therapy is unsuitable for treating type 1 diabetes.
Patients taking Glimpure MV 3.3 Tablet SR may experience side effects such as low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal discomfort, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Glimpure MV 3.3 Tablet SR components or inactive ingredients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Glimpure MV 3.3 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Indeed, Glimpure MV 3.3 Tablet SR may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimpure MV 3.3 Tablet SR
203
MRP 248
17% off